Publications

6-MOMIPP, a novel brain-penetrant anti-mitotic indolyl-chalcone, inhibits glioblastoma growth and viability

Du et al. (2018). Cancer Chemotherapy and Pharmacology. doi: 10.1007/s00280-018-3726-1

View article (DOI)